Issue 6/2015
Content (7 Articles)
Simulation and Matching-Based Approaches for Indirect Comparison of Treatments
K. Jack Ishak, Irina Proskorovsky, Agnes Benedict
A Practical Guide for Using Registry Data to Inform Decisions About the Cost Effectiveness of New Cancer Drugs: Lessons Learned from the PHAROS Registry
Hedwig M. Blommestein, Margreet G. Franken, Carin A. Uyl-de Groot
Pharmacological Management of Chronic Lower Back Pain: A Review of Cost Effectiveness
Marion Haas, Richard De Abreu Lourenco
Welfarism Versus Extra-Welfarism: Can the Choice of Economic Evaluation Approach Impact on the Adoption Decisions Recommended by Economic Evaluation Studies?
James Buchanan, Sarah Wordsworth
Cost Effectiveness of Dipeptidyl Peptidase-4 Inhibitors for Type 2 Diabetes
Jinsong Geng, Hao Yu, Yiwei Mao, Peng Zhang, Yingyao Chen
Cost-Utility Analysis of a Medication Review with Follow-Up Service for Older Adults with Polypharmacy in Community Pharmacies in Spain: The conSIGUE Program
Francisco Jódar-Sánchez, Amaia Malet-Larrea, José J. Martín, Leticia García-Mochón, M. Puerto López del Amo, Fernando Martínez-Martínez, Miguel A. Gastelurrutia-Garralda, Victoria García-Cárdenas, Daniel Sabater-Hernández, Loreto Sáez-Benito, Shalom I. Benrimoj
Erratum to: Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex®) for Spasticity in Multiple Sclerosis
Lanting Lu, Hilary Pearce, Chris Roome, James Shearer, Iain A. Lang, Ken Stein